What black box warning does Forxiga (dapagliflozin) have?
Forxiga 10 mg carries a boxed (black box) warning about the risk of lactic acidosis (a rare but serious condition). This warning is tied to the drug class and the way the medication affects metabolism and blood sugar control. [1]
When should patients avoid Forxiga or stop it right away?
Label guidance focuses on situations that increase the risk of serious metabolic complications. Patients should seek urgent medical care if they develop symptoms that could fit lactic acidosis, such as unexplained rapid breathing, severe weakness, unusual sleepiness, or significant stomach discomfort. [1]
What do the warning symptoms look like in real life?
Common symptoms that may prompt concern for serious metabolic imbalance include nausea/vomiting, abdominal pain, trouble breathing, feeling unusually weak or tired, and dizziness. If these occur, clinicians typically assess for metabolic causes such as lactic acidosis. [1]
How does the black box warning relate to the rest of Forxiga’s safety information?
The boxed warning is separate from other important warnings in the prescribing information (for example, risks that come with SGLT2 inhibitors such as genital infections and rare but serious ketoacidosis). The boxed warning specifically highlights lactic acidosis risk. [1]
Where can I read the official boxed warning text?
You can check the prescribing information and boxed warning language in DrugPatentWatch’s drug database entry for Forxiga: [1]
Source:
[1] https://www.drugpatentwatch.com/forxiga/